October 2014


In this Issue

Safety In SFA Intervention

Practical Strategies to Advance the Protection of Patients and Operators.




Safety in SFA Intervention

By Marianne Brodmann, MD, and John R. Laird Jr, MD

Cover Stories

TVR Reduction in the SFA

How do current TVR reduction rates compare with earlier values?

By Koen Deloose, MD; Marc Bosiers, MD; and Joren Callaert, MD

Utility of Procedural Checklists in SFA Interventions

The use of checklists can improve outcomes and ensure the safety and efficiency of endovascular SFA procedures.

By Michael S. Hong, MD, and David L. Dawson, MD

Managing Perforations of the Superficial Femoral Artery

How to prevent and treat these endovascular complications.

By Warren Swee, MD, MPH; Jeffrey Y. Wang, MD; and Arthur C. Lee, MD

Acute Arterial Thrombosis Prevention and Management During SFA and Popliteal Interventions

Acute limb ischemia carries a serious short-term risk, and knowing the ins and outs of treatment options is crucial for lowering the rates of morbidity, mortality, and amputation.

By George L. Adams, MD, MHS, and O Jesse Mendes, BA

Distal Embolization in Femoropopliteal Interventions

An overview on how to handle this complication and—better yet—how to prevent it with the use of embolic protection devices.

By Nicolas W. Shammas, MD, MS, FACC, FSCAI

Strategies for Femoropopliteal In-Stent Restenosis

An overview on the safety and efficacy of current devices and treatment techniques to overcome this challenging but often-occurring clinical presentation.

By Ehrin J. Armstrong, MD, MSc

When would you elect to use a DCB versus a DES for SFA interventions, and what guides your decision making?

With Francesco Liistro, MD; Sebastian Sixt, MD; Gary Ansel, MD; and Marianne Brodmann, MD

Factors Affecting Reduction in SFA Stent Fracture Rates

From first-generation to new stents, examining how design has an impact on fracture rates in the SFA.

By Martin Werner, MD

Keeping the Room Out of the Patient

Reducing the risk of foreign body embolization during interventional procedures.

By John R. Laird, MD, FACC, FACP, FSCAI

How concerned are you regarding radiation exposure over a high volume of challenging SFA cases, and what safety measures has your facility implemented?

With Jos C. van den Berg, MD, PhD; Christopher W. Boyes, MD; Koen Deloose, MD; Larry J. Diaz-Sandoval, MD, FACC, FSCAI; Prof. Dr. Erich Minar; and Thomas P. Davis, MD, FACC

Featured Technology

Sponsored by Abbott Vascular

An Advanced Solution for SFA Disease: Vascular Mimetic Implants

Perspectives on the use of the Supera® peripheral stent system.

By Craig Walker, MD, and Joseph J. Ricotta II, MD, MS


Sponsored by Volcano Corporation

Optimizing PAD Treatment With the Phoenix Atherectomy System

A look at the next generation of peripheral atherectomy, including case reports courtesy of Prof. Thomas Zeller, MD.

By Stephen B. Williams, MD, MPH

European Featured Technology

Sponsored by Cordis Corporation

The S.M.A.R.T.® Flex Vascular Stent System Solution

Technical considerations and clinical results in treating extensive femoropopliteal occlusive disease.

By Peter Goverde, MD; Kim Taeymans, MD; and Katrien Lauwers, MD


First CMS Attempt at Transparency Is Remarkably Cloudy

A search for clarity in the initial Open Payments experience.

By Steven J. Cagnetta, Esq, and Steven K. Ladd



A preview of today's new products.

An Interview With Prof. Giovanni Torsello, MD

The President-Elect of the German Society of Vascular Surgery reflects on the impact of endovascular treatment developments during his career and the importance of proper training for optimal outcomes.


Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.